Center for Regenerative Medicine - Cord Blood Stem Cells

The CBR Center for Regenerative Medicine to Help Initiate Hearing Loss Study

Cord Blood Registry also announced today that it is in discussions with three leading medical institutions to launch a clinical study that will evaluate the use of a child's own newborn stem cells to treat hearing loss caused by an accident or severe illness.

The research will be facilitated and coordinated by The CBR Center for Regenerative Medicine, which was established by Cord Blood Registry as a scientific research collaborative with leading medical research institutions from around the country. The company estimates that more than 600 children already banked with CBR may have some form of severe hearing loss. The CBR Center for Regenerative Medicine is currently screening potential candidates for this study.